Mednet Logo

How would you treat a potentially resectable stage III lung adenocarcinoma with an EGFR mutation?

Do you consider any neoadjuvant therapy or proceed to surgery followed by adjuvant chemotherapy and osimertinib? Does the type of mutation (ex a rare exon 19 mutation) change affect your decision?
Community PollStarted

How would you treat a patient with potentially resectable stage III lung adenocarcinoma with an EGFR mutation?

53 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Albert Einstein College of Medicine at Montefiore Medical Center
Answered on

How would you treat a potentially resectable stage III adenocarcinoma with an EGFR mutation?
Do you consider any neoadjuvant therapy or proceed to surgery followed by adjuvant chemotherapy and osimertinib?

This is a very challenging patient scenario that we face with some frequency and it truly is l...

Join for free or sign in to see the full answer